Board Meetings for AJANTPHARM
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| AJANTPHARM | Ajanta Pharma Limited | 03 Nov 2020 | Buyback | To consider buyback for equity shares.This is with reference to our letter dated 23rd October 2020, informing you about the Board Meeting of the Company scheduled to be held on Tuesday, 3rd November, 2020 ("Board Meeting"), to consider, inter alia the unaudited consolidated and financial results for the quarter and half year ended 30th September 2020 and interim dividend.Pursuant to Regulation 29(1)(b) of Listing Regulations, we hereby inform you that, at the aforesaid Board Meeting, the Board of Directors will also consider a proposal for buy-back of the Equity Shares of the Company including matters related /incidental thereto ("Buyback") and any other matter as the Board of Directors of the Company may decide during the course of the meeting.You are requested to please take a note of the same. | |
| AJANTPHARM | Ajanta Pharma Limited | 03 Nov 2020 | Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2020 and dividend | |
| AJANTPHARM | Ajanta Pharma Limited | 30 Jul 2020 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 | |
| AJANTPHARM | Ajanta Pharma Limited | 20 May 2020 | Financial Results | To consider and approve the financial results for the period ended March 31, 2020 | |
| AJANTPHARM | Ajanta Pharma Limited | 05 Feb 2020 | Financial Results | To consider and approve the financial results for the period ended December 31, 2019 | |
| AJANTPHARM | Ajanta Pharma Limited | 05 Nov 2019 | Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2019 and dividend | |
| AJANTPHARM | Ajanta Pharma Limited | 31 Jul 2019 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 | |
| AJANTPHARM | Ajanta Pharma Limited | 30 Apr 2019 | Financial Results | To consider and approve the financial results for the period ended March 31, 2019 | |
| AJANTPHARM | Ajanta Pharma Limited | 30 Jan 2019 | Financial Results | To consider and approve the financial results for the period ended December 31, 2018 | |
| AJANTPHARM | Ajanta Pharma Limited | 30 Jan 2019 | Buyback | To consider buyback for equity shares | |
| AJANTPHARM | Ajanta Pharma Limited | 31 Oct 2018 | Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2018 and dividend | |
| AJANTPHARM | Ajanta Pharma Limited | 31 Jul 2018 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 | |
| AJANTPHARM | Ajanta Pharma Limited | 02 May 2018 | Financial Results | To consider and approve the financial results for the period ended March 31, 2018 | |
| AJANTPHARM | Ajanta Pharma Limited | 25 Jan 2018 | Results | To consider and approve inter-alia, Unaudited consolidated and standalone Financial Results of the Company for the third quarter ended December 31, 2017. | |
| AJANTPHARM | Ajanta Pharma Limited | 31 Oct 2017 | Results | To consider and approve inter-alia, Unaudited consolidated and standalone Financial Results of the Company for the second quarter and half year ended September 30, 2017. |